Brii Biosciences Limited
BRIBF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1,347,555 | $669,129 | $665,361 | $1,189,076 |
| - Cash | $1,507,500 | $1,003,365 | $656,256 | $489,650 |
| + Debt | $7,390 | $28,020 | $19,716 | $3,156 |
| Enterprise Value | -$152,555 | -$306,216 | $28,821 | $702,582 |
| Revenue | $497 | $13,891 | $22,155 | $16,225 |
| % Growth | -96.4% | -37.3% | 36.5% | – |
| Gross Profit | $497 | $13,891 | $22,155 | $16,225 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$86,565 | -$93,566 | -$213,280 | -$275,204 |
| % Margin | -17,435% | -673.6% | -962.7% | -1,696.2% |
| Net Income | -$74,034 | -$113,814 | -$280,535 | $15,088 |
| % Margin | -14,911.1% | -819.4% | -1,266.2% | 93% |
| EPS Diluted | -0.1 | -0.16 | -0.38 | 0.021 |
| % Growth | 37.5% | 57.9% | -1,926.9% | – |
| Operating Cash Flow | $0 | -$147,102 | -$225,788 | -$240,253 |
| Capital Expenditures | $0 | -$2,463 | -$765 | $0 |
| Free Cash Flow | $0 | -$149,565 | -$226,553 | -$240,253 |